Can measuring brain function help us choose an antidepressant? ↗
Keep the psychosis ACE study distinct from depression biomarkers while comparing what connects a measurable difference to treatment selection or molecular function.
Frontier Science · TOPIC v1
ACE levels are lower. Which functions have changed?
Which changes in ACE abundance, catalytic activity or localization matter for neural function and disease?
Read article → ACE levels are lower. Which functions have changed?
2026-10-24 05:23:44.516 UTC · Last recorded update
CURRENT READING
The study reports lower ACE protein abundance associated with early-stage psychosis and treatment resistance, but no significant group difference in enzyme activity per unit serum volume.
Recorded editorial state, not a maturity score
- Association observed in patientsRecorded
- Disentangle functionsUnverified
- Causal links to diseaseUnverified
New question opened · v1
Separate early-psychosis observations, prior depression research and editorial experimental proposals.
Permanent link to this revision ↗01 / WHAT WE TRACK
Which changes in ACE abundance, catalytic activity or localization matter for neural function and disease?
02 / EVIDENCE & TECHNOLOGY
ACE abundance / catalytic activity / localization / neural circuits
03 / EDITORIAL READING
The outcome of a single ACE inhibitor cannot determine ACE’s overall involvement or roles. The findings motivate tests separating abundance, catalytic activity and localization.
04 / WHAT REMAINS UNKNOWN
This cross-sectional association does not establish causal function or efficacy in depression. Earlier captopril findings also do not prove a nonenzymatic role for ACE.
05 / NEXT CHECK
Separate abundance, activity and localization in patient-derived cells and mice; distinguish circuit and behavioral measures from blood-pressure and locomotor effects.
A hypothesis to keep honest
HYPOTHESIS · NOT YET TESTEDInvestigating the mismatch between ACE abundance and measured activity may identify unresolved roles in neural function.
What would change our view: Reconsider the hypothesis if separated manipulations do not reproduce predicted neural effects or associations are explained by confounding or peripheral effects.
A prospective test proposal, not a prediction score. A graph connection does not validate this hypothesis.
Linked people & organizations
Open an entity to find its cardsINSTITUTION / INFRASTRUCTUREJohns Hopkins Medicine ↗
Mentioned in this issue
INSTITUTION / INFRASTRUCTUREAngiotensin-converting enzyme ↗
Mentioned in this issue
Related questions, optional follows
Map ↗Latest card updates
Latest 5 · editorial record dates- v1 · 2026-10-24 05:23:44.516 UTCNew question opened
Separate early-psychosis observations, prior depression research and editorial experimental proposals.
Reading at the time: The study reports lower ACE protein abundance associated with early-stage psychosis and treatment resistance, but no significant group difference in enzyme activity per unit serum volume.
Earlier updates (0)
Earlier entries will appear here once more than five reader-facing revisions have accumulated.
Background readings
Source dates and verification scope
ACE protein abundance, activity and early-stage psychosis ↗
JAMA Psychiatry · 2026-09-09 · peer-reviewed-study
Captopril and depressive-type behaviors: bradykinin-dependent mTORC1 activation ↗
Biological Psychiatry · 2020-02-18 · peer-reviewed-study
Antihypertensive drugs and depression: nationwide observational study ↗
Hypertension · 2020-08-24 · peer-reviewed-study
ACE inhibitors / ARBs and depression risk in older people with hypertension ↗
Journal of Psychopharmacology · 2022-04-07 · peer-reviewed-study
ACE and treatment-resistant psychosis: institutional explanation ↗
Johns Hopkins Medicine · 2026-10-12 · research-institution-commentary